Phase 1 Apathy Clinical Trials

2 recruitingPhase 1

What is a Phase 1 trial?

Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.

Showing 1–2 of 2 trials

Recruiting

Phase 1Phase 2

Safety and Tolerability of IRL757 in Participants With Parkinson's Disease and Apathy

SafetyPARKINSON DISEASE (Disorder)Apathy

Integrative Research Laboratories AB75 enrolled13 locationsNCT07461220

Recruiting

Phase 1Phase 2

Accelerated rTMS vs. Sham for Stroke Apathy

StrokeMotivationApathy+4 more

Medical University of South Carolina40 enrolled1 locationNCT07113067